MT-ND4 and Leber hereditary optic neuropathy: Currently, the only ongoing gene therapy clinical trials in a primary mitochondrial disease is in an ocular disease: Leber’s hereditary optic neuropathy (LHON), which is caused by the mitochondrially-encoded MT-ND4 gene (Slone and Huang, 2020).